z-logo
open-access-imgOpen Access
Mesenchymal stem cells, Vitamin and Zinc as therapeutic cells and factors of COVID-19
Author(s) -
Jamshid Ayatollahi,
Seyed Hossein Shahcheraghi,
Marzieh Lotfi,
Mahdie Hamidfar,
Mohammad Dehghan Niri,
Azam Fazilati
Publication year - 2020
Publication title -
chinese journal of medical research
Language(s) - English
Resource type - Journals
eISSN - 2663-8053
pISSN - 2618-091X
DOI - 10.37515/cjmr.091x.3301
Subject(s) - covid-19 , coronavirus , mesenchymal stem cell , virology , medicine , outbreak , disease , infectious disease (medical specialty) , pathology
2019 Coronavirus disease (COVID-19) occurred in Wuhan City, Central China, and has spread rapidly in many countries in world. COVID-19 is produced by a new coronavirus called the extreme acute respiratory coronavirus syndrome 2 (SARS-CoV2) [Recently identified as the 2019 novel coronavirus (2019- nCoV)] [1]. However, there was no official approval of an antiSARS-CoV-2 drug or vaccine due to the lack of sufficient evidence. Scientists are trying to improve COVID-19 by the new drugs and methods [2].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom